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ABSTRACT The binding site interactions between the
phosphoryicholine (phosphocholine-binding mouse myeloma
proteins TEPC 15, W3207, McPC 603, MOPC 167, and MOPC
511 and the isotosicalli substituted hapten Vhosphoryl-13C]cholinetave teen investigated using 3C and 31P
nuclear magnetic resonance (NMR) spectroscopy. Each protein
exhibits a unique NMR pattern, but extensive similarities in
chemical shift parameters upon binding of hapten to immuno-
globulin suggest a significant degree of conservation of im-
portant hapten-binding site interactions. Moreover, independent
inding studies, in conjunction with the NMR data, allow
construction of a simple model of the binding sites of these an-
tibodies, analyzed in terms of the relative strength of interaction
between hapten and two main subsites. The NMR evidence
supports the view that the heavy chains of these proteins dom-
inate in interacting with bound phosphorylcholine; the various
subspecificities of these proteins for phosphorylcholine ana-
logues can be accounted for by amino acid changes in the hy-
pervariable regions of the heavy chains.
The heavy and light chains of an antibody cooperate to form
the specificity site for recognition of a particular antigen. This
work is aimed at exploring the degree to which these two chains
determine specificity and the effect of small structural changes
in the antibody on the molecular aspects of its interaction with
antigens.
A number of myeloma proteins produced by plasmacytomas
of BALB/c mice have been found to interact specifically with
phosphorylcholine (P-Cho; the name phosphocholine is rec-
ommended by the International Union of Pure and Applied
Chemistry) (1-3) and sequence analysis of the heavy chains of
several of these proteins (4, 5) has revealed a degree of homol-
ogy greater than 85%. Though still incomplete, the sequence
data on the light chains suggest a division into at least three
subsets with sequences differing widely between members of
different subsets (6-8). Though these antibodies have similar
affinities for P-Cho, they exhibit different affinities for its
structural analogues (9). Because of the extensive homology of
the heavy chains in these proteins and the correlation between
the subspecificity of an individual protein and the subgroup of
the light chain, the heavy chain may well be the principal de-
terminant of the specificity for P-Cho while the light chain
"fine tunes" the subspecificity (8).
The antibodies studied to date show a high degree of con-
servation of their tertiary and quaternary structures. Thus, one
can construct plausible three-dimensional binding sites using
sequence data together with structural information obtained
by x-ray diffraction studies of other, related immunoglobulins.
For example, the three-dimensional structure of the Fab'
fragment of M603, a typical mouse myeloma protein that binds
P-Cho, has been determined to 3.1 A resolution (10). This in-
formation, together with the existence of a well-characterized
group of similar immunoglobulins, has afforded the opportunity
to study the molecular details of structure-function relationships
and, in particular, to assess the importance of individual chains
and amino acid residues to the interactions between antibody
and antigen (11). Such studies should help to reveal the mo-
lecular source of the exquisite discriminatory powers exhibited
by the immune response.
We have previously discussed the use of 31P and 13C mag-
netic resonance techniques to study the binding of P-Cho to
M603 (12) and now extend this type of study to four other
myeloma proteins that specifically bind P-Cho. In this report
we emphasize differences in interaction between antibody and
hapten caused by changes of amino acids in the subregions of
the antibody binding site.
MATERIALS AND METHODS
Plasmacytomas TEPC 15 (abbreviated T15), McPC 603
(M603), and W3207 were obtained from the Salk Institute, San
Diego, CA; MOPC 167 (M167) and MOPC 511 (M511),
through the courtesy of Dr. Leroy Hood. [methyl-'4C]Choline
chloride was purchased from New England Nuclear and L-
a-glycerophosphorylcholine (95%) from Sigma. Phosphono-
choline was a gift from Dr. Leroy Hood. Purification of protein
and the experimental details have been described elsewhere
(12).
The numbering system of heavy chain amino acids is that of
Rudikoff and Potter for M603 (13).
RESULTS
Table 1 summarizes data obtained by equilibrium dialysis on
the thermodynamics of binding by five myeloma proteins to-
gether with background information. Our binding constants
(Kas) for P-Cho agree reasonably well with published results
(3, 14-16). The binding constant for W3207 is larger than for
any other myeloma protein studied to date. As previously
suggested (1), M511 shows a relatively high affinity for cho-
line.
Table 2 summarizes 31P and 13C nuclear magnetic resonance
(NMR) results of interactions between the various proteins and
phosphoryl[methyl- 13C]choline. Binding of hapten to antibody
generally causes a 1.2-1.3 ppm upfield shift of the 13C methyl
resonance relative to its position when free in solution; M603
provides the exception with a smaller upfield shift of 0.7 ppm.
The 31P resonance moves 1.5 ppm upfield on binding for all of
the proteins with the exception of M167, for which the chemical
shift for the bound form is the same as for the hapten free in
solution.
Because the value of the dissociation rate constant of the
antibody-hapten complex, koff, is similar to the change in
chemical shift occasioned by binding of hapten to antibody,
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Table 1. Properties of phosphoryicholine-specific myeloma proteins
Myeloma protein
Property T15 W3207 M603 M167 M511 Ref.
Idiotype A ?(*A) B C D 1, 20
Light chain subgroup I II II III III 5-7
Number of heavy chain
differences from T15 0 7 5 13 5 5
Phosphoryicholine Ka X 10-5, M-'
40 17.5 30.4 8.2 7.4 0.43
300 3.5 7.0 1.0 1.2 0.15
Subspecificity*
Choline 550 600 870 10 3
L -a-Glycerophosphorylcholine 11 4 10 0.8 0.7
Phosphonocholine 95 15 11 33
* Represented as Ka (phosphorylcholine)/Ka (inhibitor). Data for W3207 and M511 were determined by direct equilibrium dialysis (choline)
or inhibition of phosphorylcholine binding (L-a-glycerophosphorylcholine and phosphonocholine) at 4°. Data for T15, M603, and M167 are
taken from Leon and Young (9).
exchange-broadened resonances were observed in all cases but
with differences characteristic of each protein. For example,
binding of excess P-Cho to W3207, M603, and M167 resulted
in separate peaks corresponding to free and bound hapten for
both the 13C and 31P signals, whereas binding to M511 resulted
in a single resonance corresponding to the weighted average
of the two environments. Binding of P-Cho to T15 gave two
separate 3lp signals but only a single greatly broadened 13C
resonance. Table 2 also collects the values of koff, estimated from
the observed change in chemical shift on binding and the extent
of exchange broadening, as well as the calculated values of the
rate constant for association (kon = Ka-koff). Except for M603,
the rate constants from the '3C and 31p observations are in good
agreement.
DISCUSSION
Subsite Interactions among Phosphorylcholine-
Binding Myeloma Proteins. Particular regions of the binding
site responsible for a certain type of interaction (e.g., electro-
static, hydrogen bonding, or hydrophobic) with a portion of the
bound ligand have been termed interaction subsites; their
existence was postulated by Haselkorn et al. (17) as a result of
kinetic experiments on a myeloma protein that binds dinitro-
phenyl derivatives. In this model, the total binding energy
represents an appropriate summation of the contributions from
each individual subsite-ligand interaction. This serves as a
convenient basis for our discussion of the binding of P-Cho or
its analogues to myeloma proteins with specificity for P-
Cho.
For binding of P-Cho one may envision three subsites as
contributing substantially to hapten binding: a negatively
charged subsite for interaction with the positive quaternary
nitrogen; a positive, possibly hydrogen-bond-donating subsite
for interaction with the dianionic phosphate; and a hydrophobic
subsite for interaction with the two central methylene groups
of P-Cho. Specific electrostatic interactions, consistent with the
first two of these postulated subsites, have been observed in the
three-dimensional structure of the binding site of M603 which
was determined by x-ray diffraction (10).
For consideration of the phosphate-binding subsite, proteins
T15, W3207, and M603 are useful. These all cause identical
hapten 31P shifts and show similar koff rates calculated from
their 3lp spectra, suggesting similar subsite interactions with
the phosphate group. Their affinity for choline is lower by a
factor of 600-900 than that for P-Cho, as would be anticipated
if interactions with the dianionic phosphate group are important
for binding. Also, their affinity for L-a-glycerophosphoryl-
choline is lower by a factor of 4-10 compared to P-Cho,
suggesting steric interference and/or loss of electrostatic binding
interaction when the larger, monoanionic L-a-glycerophosphate
group binds in the phosphate pocket. These results indicate that,
for these three proteins, the phosphate subsites are probably
very similar; their different absolute affinities for each of P-
Cho, choline, and L-a-glycerophosphorylcholine arise from
differing interactions with the trimethylammonium region of
these ligands. The 13C NMR results support this view and imply
that M603 interacts differently than do T15 and W3207 with
the methyl groups of the hapten. In addition, different koff rates
were calculated from the '3C spectra of labeled hapten inter-
acting with these three proteins. Though M603 binds P-Cho
less strongly than do T15 and W3207, M603 nevertheless has
Table 2. Phosphorylcholine chemical shifts and kinetic rate constants obtained
with phosphorylcholine-specific myeloma proteins
Myeloma protein
Property T15 W3207 M603 M167 M511
13C shift on binding, ppm 1.3 1.2 0.7 1.3 1.2
31Pshift on binding, ppm 1.5 1.5 1.5 0 1.5
koff from 13C spectra, sec&' 107 34 10 53 195
koff from 31p spectra, sec-' 63 47 38 189
kon x 10-6 from 13C spectra, M-' sec-t 37 24 0.94 6.4 2.9
kon x 10-6 from 31P spectra, M-' sec-' 22 33 3.8 - 2.8
Proc. Nati. Acad. Sci. USA 74 (1977)
Proc. Natl. Acad. Sci. USA 74 (1977) 2111
Table 3. Postulated strength of subsite interactions of
phosphorylcholine-specific myeloma proteins
Myeloma protein
T15 W3207 M603 M167 M511
Choline subsite ++ +++ ++- +++ +
Phosphate subsite +++ +++ ++ + +
Total 5+ 6+ 4+ 4+ 2+
Ka X 10-5, M-1
(300) 3.5 7.0 1.0 1.2 0.15
+, weak; ++, moderate; +++, strong
a lower value of koff, which requires that it have a substantially
lower association rate constant than do T15 and W3207.
Comparative affinities do not, however, always correlate with
subsite interactions, as is demonstrated by comparison of
binding by M167 and M511, both of which have affinities for
choline comparable to those for P-Cho although they have quite
different binding site interactions. For example, M167 is unique
among the proteins studied in causing no shift of the 31P hapten
resonance on binding, suggesting a very different subsite for
binding the phosphate group (see below). The choline subsite
of M167 appears, however, to be very similar to the subsites of
T15 and W3207. Though the hapten 13C and 31P shifts induced
by binding to M511 are both similar to those seen on binding
to T15 and W3207 (indicating similar interactions with the
phosphate and trimethylammonium groups of the hapten), the
dissociation rate constant of the M51 1-phosphorylcholine
complex is an order of magnitude higher than that of the other
proteins and is reflected in a decreased binding constant. This
unexpectedly low affinity cannot be traced to noticeably dif-
ferent interactions between antibody and trimethylammonium
or phosphate group, but appears due to a generally poorer
complementarity between hapten and binding site.
Table 3 summarizes the postulated subsite interactions de-
ducible from the NMR and binding data. One sees that affinities
for P-Cho and related haptens can be modulated by structural
changes in relatively independent subregions of the binding
pockets of these antibodies, which are known to exhibit diverse
specificities for a variety of bacterial antigens (3, 18), a diversity
which likely arises from these differences in subsites.
Comparison of the dynamic aspects of hapten binding by
these five proteins shows that differences in affinity result not
only from differing dissociation constants reflecting, probably,
differences in complementarity between antibody and hapten,
but also from differing association rate constants. The calculated
association rate constants are typical of those previously ob-
served for other antibody-hapten systems (17, 19-21) and in
particular, the kon value of 4.6 X 107 M-1 sec-I calculated by
Pecht (19) for HOPC 8 agrees with our estimates of 2 to 4 X 107
M-1 sec-I for T15, a protein idiotypically identical to HOPC
8. However, the association rate constants for M603, M167, and
M511 are lower by an order of magnitude than those for T15
and W3207, indicating that T15 and W3207 allow more ready
access of hapten to the binding pocket than do the other three
proteins.
Relation between Differences in Binding Sites and
Three-Dimensional Structure. The similarity of both the 13C
and 31P hapten chemical shifts among most of the proteins
examined suggests a high degree of similarity in the important
electrostatic interactions between hapten and binding site.
M167, however, shows an unusual phosphate-binding subsite
and M603 a unique choline subsite; we shall examine the pos-
sible molecular origins for these anomalies.
The heavy chain seems to play the dominant role in the in-
teraction between these antibodies and hapten (6). This is
supported by the high degree of conservation of heavy chain
sequence among the P-Cho-binding immunoglobulins and also
by the presence of three widely differing light chain sequences
among the five proteins. Such a view is confirmed by the
three-dimensional structure of the M603-P-Cho complex, in
which the phosphate-binding subsite is found to be formed
exclusively by heavy chain residues with the following amino
acids being in direct contact with P-Cho: Tyr 33(H), Glu 35(H),
Arg 52(H), Glu 59(H), Trp 104a(H), and an unidentified residue
at position 96 of the light chain (10, 11). The first five of these
residues, as well as the ionically important Lys 54(H), are
conserved among most of the P-Cho-binding mouse myeloma
proteins.
We have previously interpreted the 31P chemical shifts on
binding of P-Cho (+1.5 ppm) as being caused largely by hy-
drogen bonding between specific amino acid residues and the
phosphate group (12). M167 shows no such shift. Why? This
does not necessarily correlate with the relatively high affinity
of M167 for choline because M511 also has this high choline
affinity but nevertheless causes a +1.5 ppm shift for bound
P-Cho. We suggest that absence of a +1.5 ppm shift on binding
to M167 results from presence in the phosphate subsite of an
additional cationic residue, Arg 58a(H), which is unique to
M167. Examination of the M603 x-ray structure reveals that
heavy chain hypervariable region 2 (residues 50-65) forms a
crucial portion of the phosphate-binding subsite. Relative to
T15, M167 has three amino acid substitutions in this second
hypervariable region (Asn 53 - Ser, Asn 56 - His, and Thr
58a - Arg). Addition of a third cationic residue (Arg 58a) (in
addition to Arg 52 and Lys 54, both of which stablize the bound
phosphate) could cause a diamagnetic downfield effect that
offsets the upfield shift resulting from the usual hydrogen bond
formation.
Additional evidence for a strong interaction of the phosphate
subsite of M167 with the hapten comes from the increased 31P
linewidth of the bound hapten (Avl/2 = 24 Hz), which suggests
immobilization of the phosphate group of the bound hapten as
would result from formation of hydrogen bonds.
The anomalous 13C shift observed for M603 is more difficult
to rationalize because the light chain contributes to formation
of the choline subsite and sequence data for the light chains are
still incomplete. However, the other four proteins have, relative
to M603, an extra residue in the third hypervariable region of
the heavy chain [residue 103a(H)I, and such an insertion could
have a significant effect on the binding interaction in this
subsite.
Importance of Specific Chains in the Formation of a
Functional Binding Site. We would like to suggest that, to a
first approximation, the various subspecificities in these proteins
result from the independent modification of one of the two
main subsites through changes in critical heavy chain hyper-
variable residues. Such changes require the concomitant pres-
ence of a light chain that is compatible with such a specifically
altered heavy chain. This would explain the low P-Cho affinity
of heterologous hybrids of S107 and M511 (22) as well as our
observations indicating that both heterologous hybrids of T15
and M167 have affinities for P-Cho of less than 104 M-1. Thus,
though it may not extensively interact directly with the hapten,
the light chain plays a critical role in determining antibody
specificity by serving as a precisely complementary structure
with which the heavy chain can join in a mutual embrace to
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create the binding site. Padlan et al. (11) have pointed out that
the extensive contact between light chain hypervariable region
1 and heavy chain hypervariable region 3 in M603 could be an
example of one way in which highly specific light-heavy chain
pairing is achieved in P-Cho-binding proteins.
The tendency for proteins containing the same type light
chain to share similar subspecificities even though dissimilar
environments for bound P-Cho are observed by NMR allows
the possibility that the light chain, though largely uninvolved
in contacting the important regions of the ligand, nevertheless
indirectly affects ligand binding properties through synergistic
interactions with the heavy chain.
Comparison of Phosphorylcholine-Binding Sites. We may
now summarize our understanding of the individual binding
sites of these proteins. W3207, which has the highest affinity
for P-Cho, forms strong interactions with both ends of the
hapten. T15 has differences from W3207 in the third hyper-
variable region of its heavy chain which, by analogy to the x-ray
structure of M603, would be expected to influence mainly the
subsite for choline. Accordingly, T15 exhibits slightly weaker
interactions in this subsite, but retains the strong phosphate
subsite interactions of W3207; the net result is a 2-fold decrease
in the affinity of T15 for P-Cho. M603 retains the W3207 type
light chain but has significant differences throughout the heavy
chain, causing a substantial alteration in the choline subsite; the
overall affinity of M603 for P-Cho is reduced by a factor of 4-6
relative to that of W3207. M167 has a heavy chain with a wider
diversity from the W3207 prototype than that of any of the
other proteins. M167 also has a different type of light chain.
These changes give rise to a greatly altered phosphate subsite,
where decreased specificity is attested by the high relative af-
finity for choline and L-a-glycerophosphorylcholine. M511 has
a light chain of the M167 type and only a moderate number of
amino acid differences in its heavy chain relative to W3207;
we have no explanation for the noticeably decreased affinity
of M511 for P-Cho.
CONCLUSIONS
The generally similar hapten-binding site interactions observed
for this series -of five idiotypically distinct mouse myeloma
proteins demonstrates a general conservation of at least the
important electrostatic interactions in the binding sites of this
family of immunoglobulins. This conservation is, however, not
absolute, and deviations are observed in subregions of the
binding pockets of M167 and M603. The hapten-binding site
interactions, as monitored by the 13C and 31P nuclei of the
P-Cho hapten, correlate with the binding affinities of these
proteins for various haptens. The concept of subsite interactions
has proved especially fruitful in understanding these effects.
Among these proteins, changes in binding properties can be
accounted for largely by differences in the heavy chains, which
appear to play the dominant role in determining specificity for
P-Cho. Though the fundamental significance of the pairing of
similar heavy chains with at least three distinct types of light
chains remains obscure, hybridization experiments suggest thathigh affinity for P-Cho requires specific association betweenheavy and light chains.
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